a
Sunday 8th November 2026
|
|
|
|
12:00 – 14:00
|
Registration
|
|
14:00 – 14:20
|
Welcome session/house keeping
|
|
14:20 – 15:35
|
Workshop 1 – Protein workflows and tools
|
|
14:20 – 14:45
|
A streamlined, FAIR, ML/AI-enabled protein production workflow to progress AstraZeneca pipeline projects Lovisa Holmberg-Schiavone, AstraZeneca
|
|
14:45 – 15:10
|
Protein generation – various scales and throughputs, and how to enable efficient learnings
Maja Firczuk, GSK
|
|
15:10 – 15:35
|
Target 2035: A Roadmap for Covering the Druggable Proteome with Chemical Tools
Stefan Knapp, SGC
|
|
15:35 – 16:05
|
Tea and Coffee
|
|
16:05 – 17:20
|
Workshop 2 – Technology platforms
|
|
16:05 – 16:30
|
Development of a joint X-ray and cryo-EM platform for SBDD, Michael Saur, Astex
|
|
16:30 – 16:55
|
Cryo EM and X ray Crystallography in Concert: A Complementary Workflow for Structure Based Drug Discovery
Srinivas Honnappa, Novartis
|
|
16:55 – 17:20
|
An integrated tractability & Druggability prediction platform,
Yoana Dimitrova, Genentech
|
|
17:30 – 19:00
|
Registration/Free Time/ Poster Setup
|
|
19:00 –21:00
|
Welcome Drinks: Exhibition/Dinner
|
aa
Monday 9th November 2026a
|
09:00 – 09:15
|
Welcome session/house keeping
|
|
09:15 – 10:30
|
Session 1 – Structure based design for GPCR:s
|
|
09:15 – 09:40
|
Structure-based optimization of modulators facilitating mechanistic insights into GPCR function
Dietmar Weichert, Boehringer Ingelheim
|
|
09:40 – 10:05
|
Expanding the Allosteric Landscape of GLP-1R: Structural Insights to Guide PAM Design
Maxime Killer, Sanofi, France
|
|
10:05 – 10:30
|
TBD
|
|
10:30 – 11:20
|
Coffee and Exhibition Viewing
|
|
11:20 – 12:10
|
Session 2 – SBDD goes viral
|
|
11:00 – 11:25
|
Structure-based Optimization of a Bivalent Vaccine Against Respiratory Syncytial Virus and Human Metapneumovirus
Oliver Acton, AstraZeneca
|
|
11:25 – 12:00
|
RNA cryo-EM goes viral
Tamas Yelland, Evotec
|
|
12:10 – 12:50
|
Gold Sponsor talks
|
|
12:10 – 12:20
|
TBC
|
|
12:20 – 12:30
|
TBC
|
|
12:30 – 12:40
|
TBC
|
|
12:40 – 12:50
|
TBC
|
|
12:50 – 14:10
|
Lunch and Exhibition Viewing
|
|
14:10 – 15:00
|
Session 3 – Emerging technologies
|
|
14:10 – 14:35
|
New opportunities for neutron scattering applications for drug discovery
Zoe Fisher, European Spallation Source ERIC
|
|
14:35 – 15:00
|
Enabling a Scalable Lab-in-the-Loop Structural Biology Approach for AI-Driven Drug Discovery
Radoslav Enchev, Crick Institute
|
|
15:00-15:25
|
Atom Probe Tomography for Protein Structure Determination
Martin Andersson , Chalmers university of Technology
|
|
15:25 – 16:50
|
Coffee and Exhibition Viewing
|
|
16:50 – 17:35
|
Session 4 – Advances in AI/ML for drug discovery
|
|
15:30 – 15:55
|
Utility of co-folding methods for fragment-based drug discovery – the drama unfolds
Marcel Verdonk, Astex
|
|
15:55 – 16:20
|
Antibody–Antigen Recognition: From Structure to Machine Learning Guided Antibody Design and Discovery
Monica Fernandez-Quintero, Novo Nordisk foundation
|
|
16:50 –17:35
|
Plenary Talk Gabriele Corso, CEO and cofounder of Boltz
|
|
|
End of Day 1
|
|
19:00 – 22:00
|
Conference dinner
|
a
Tuesday 10th November 2026
|
09:00 – 09:05
|
House Keeping
|
|
09:05 – 10:20
|
Session 5 – Expanding target space
|
|
09:05 – 09:30
|
Title TBC
Chun-wa Chung GSK
|
|
09:30 – 09:55
|
Expanding target space for cryo‑EM SBDD leveraging knowledge of target biology
Ellene Mashalidis, Pfizer
|
|
09:55 – 10:20
|
Development of the macrocyclic KRAS inhibitor AUBE00 through isoform-selective derivatization of the RAS inhibitor LUNA18
Takashi Yamano, Chugai, Japan
|
|
10:20 – 10:50
|
Coffee and Exhibition Viewing
|
|
10:50 – 12:05
|
Session 6 – Methods focus
|
|
10:50 – 11:15
|
The enduring value of MX crystallography: accuracy as the foundation
Clemens Vonrhein, Global Phasing
|
|
11:15 – 11:40
|
Fragment HDX-MS Workflow for Detecting Low-Affinity Protein: Fragment Interactions
Catarina Malta, iBET Oeiras, Portugal
|
|
11:40 – 12:05
|
TBD
|
|
12:05 – 12:45
|
Gold Sponsor Talks
|
|
12:05 – 12:15
|
TBC
|
|
12:15 – 12:25
|
TBC
|
|
12:25 – 12:35
|
TBC
|
|
12:35 – 12:45
|
TBC
|
|
12:45 – 14:15
|
Lunch and Exhibition Viewing
|
|
14:15 – 15:30
|
Session 7 - Case Studies
|
|
14:15 – 14:25
|
Poster prize
|
|
14:25 – 14:50
|
Discovery of an oral STING polymerization blocker to treat inflammation
Shuai Chen, Roche China
|
|
14:50 – 15:15
|
TBD
|
|
15:15 – 15:30
|
Closing Remarks
|
|
|
End of Conference
|
a
